Phenotypic & Genotypic Characterization of Vancomycin Resistant Enterococcus Isolates from Clinical Specimens

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2014 Jan 18

PMID 24434263

Citations 37

Authors

Ira Praharaj

S Sujatha

Subhash Chandra Parija

Affiliations

Soon will be listed here.

Abstract

Background & Objectives: Enterococci have emerged as important nosocomial pathogens and emergence of resistance to many of the antimicrobials used for Gram-positive organisms has made the management of infections due to Enterococcus species difficult. Resistance to glycopeptide antibiotics, especially vancomycin is of special concern. This study was undertaken to perform a phenotypic and genotypic characterization of vancomycin resistant Enterococcus (VRE) isolates obtained from clinical samples in a tertiary care hospital in southern India.

Methods: Susceptibility testing was performed for Enterococcus isolates collected over a period of one year (November 2008-October 2009). Minimum inhibitory concentrations (MIC) of vancomycin and teicoplanin were determined for the isolates by the agar dilution method. Genotypic characterization of VRE isolates was done by performing multiplex polymerase chain reaction (PCR) for detecting the various vancomycin resistance genes.

Results: Of the 367 isolates of Enterococcus species isolated, 32 were found to be resistant to vancomycin after MIC testing. VanA was the commonest phenotype of vancomycin resistance and the commonest genotype was vanA. Among the other important findings of the study was the presence of heterogeneity in isolates of VRE with the vanA gene cluster with regards to resistance to teicoplanin and the coexistence of vanA and vanC1 gene clusters in an isolate of E. gallinarum which conferred high level glycopeptide resistance to the isolate.

Interpretation & Conclusions: Enterococcus species have emerged as important nosocomial pathogens in our patients with a capacity to cause a variety of infections. The vancomycin resistance among Enterococcus isolates was 8.7 per cent in our study which was high compared to other Indian studies. VanA was the commonest phenotype of glycopeptide resistance and vanA was the commonest vancomycin resistance gene. The study also demonstrates phenotypic as well as genotypic heterogeneity among isolates of VRE from clinical specimens.

Citing Articles

Prevalence of Enterococcus Species in Various Clinical Samples and Their Antimicrobial Susceptibility Pattern.

Mahajan M, Shinde R, Karande G, Patil S Cureus. 2024; 16(11):e72836.

PMID: 39624535 PMC: 11608916. DOI: 10.7759/cureus.72836.

Non- non- enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance.

Mullally C, Fahriani M, Mowlaboccus S, Coombs G Clin Microbiol Rev. 2024; 37(2):e0012123.

PMID: 38466110 PMC: 11237509. DOI: 10.1128/cmr.00121-23.

isolated from poultry intestine for potential probiotic use.

Carvajal E, Contreras S, Diaz W, Martinez-Bello D, McCown M, Ardila Y Vet World. 2023; 16(8):1605-1614.

PMID: 37766704 PMC: 10521174. DOI: 10.14202/vetworld.2023.1605-1614.

A Study on Glycopeptide-Resistant Genotypes among Clinical Isolates of with Van B Phenotype.

Rajan R Adv Biomed Res. 2023; 12:196.

PMID: 37694237 PMC: 10492609. DOI: 10.4103/abr.abr_133_21.

Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: a systematic review and meta-analysis.

Smout E, Palanisamy N, Valappil S Antimicrob Resist Infect Control. 2023; 12(1):79.

PMID: 37605268 PMC: 10441759. DOI: 10.1186/s13756-023-01287-z.

References

Murray B . Vancomycin-resistant enterococcal infections. N Engl J Med. 2000; 342(10):710-21. DOI: 10.1056/NEJM200003093421007. View

Lee W, Huh J, Cho S, Lim Y . Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements. Antimicrob Agents Chemother. 2004; 48(4):1379-81. PMC: 375328. DOI: 10.1128/AAC.48.4.1379-1381.2004. View

Ntokou E, Stathopoulos C, Kristo I, Dimitroulia E, Labrou M, Vasdeki A . Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2012; 67(8):1819-23. DOI: 10.1093/jac/dks146. View

Evers S, Courvalin P . Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995; 33(1):24-7. PMC: 227872. DOI: 10.1128/jcm.33.1.24-27.1995. View

Mathur P, Kapil A, Chandra R, Sharma P, Das B . Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res. 2004; 118:25-8. View

Low D, Keller N, Barth A, Jones R . Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001; 32 Suppl 2:S133-45. DOI: 10.1086/320185. View

Rahim S, Pillai S, Gold H, Venkataraman L, Inglima K, Press R . Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis. 2003; 36(11):E146-8. DOI: 10.1086/374929. View

Blaimont B, Wauters G, Courvalin P . Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother. 1994; 38(7):1675-7. PMC: 284616. DOI: 10.1128/AAC.38.7.1675. View

Qu T, Zhang J, Zhou Z, Wei Z, Yu Y, Chen Y . Heteroresistance to teicoplanin in Enterococcus faecium harboring the vanA gene. J Clin Microbiol. 2009; 47(12):4194-6. PMC: 2786671. DOI: 10.1128/JCM.01802-09. View

10.

Kapoor L, Randhawa V, Deb M . Antimicrobial resistance of enterococcal blood isolates at a pediatric care hospital in India. Jpn J Infect Dis. 2005; 58(2):101-3. View

11.

Agarwal J, Kalyan R, Singh M . High-level aminoglycoside resistance and beta-lactamase production in enterococci at a tertiary care hospital in India. Jpn J Infect Dis. 2009; 62(2):158-9. View

12.

. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8):470-85. DOI: 10.1016/S0196655304005425. View

13.

Pai M, Rodvold K, Schreckenberger P, Gonzales R, Petrolatti J, Quinn J . Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2002; 35(10):1269-72. DOI: 10.1086/344177. View

14.

Taneja N, Rani P, Emmanuel R, Sharma M . Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. Indian J Med Res. 2004; 119(2):72-4. View

15.

Arias C, Murray B . Antibiotic-resistant bugs in the 21st century--a clinical super-challenge. N Engl J Med. 2009; 360(5):439-43. DOI: 10.1056/NEJMp0804651. View

16.

Schooneveldt J, Marriott R, Nimmo G . Detection of a vanB determinant in Enterococcus gallinarum in Australia. J Clin Microbiol. 2001; 38(10):3902. PMC: 87507. DOI: 10.1128/JCM.38.10.3902-3902.2000. View

17.

Facklam R, Collins M . Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989; 27(4):731-4. PMC: 267406. DOI: 10.1128/jcm.27.4.731-734.1989. View

18.

Gu L, Cao B, Liu Y, Guo P, Song S, Li R . A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. Diagn Microbiol Infect Dis. 2008; 63(1):70-5. DOI: 10.1016/j.diagmicrobio.2008.08.018. View

19.

Camargo I, Barth A, Pilger K, Seligman B, Machado A, Darini A . Enterococcus gallinarum carrying the vanA gene cluster: first report in Brazil. Braz J Med Biol Res. 2004; 37(11):1669-71. DOI: 10.1590/s0100-879x2004001100012. View

20.

Eom J, Hwang I, Hwang B, Lee J, Lee Y, Cheong H . Emergence of vanA Genotype Vancomycin-Resistant Enterococci with Low or Moderate Levels of Teicoplanin Resistance in Korea. J Clin Microbiol. 2004; 42(4):1785-6. PMC: 387564. DOI: 10.1128/JCM.42.4.1785-1786.2004. View